Exforge HCT - amlodipine valsartan and hydrochlorothiazide
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0561 |
| Proprietary Name: | Exforge HCT |
| Suffix: | |
| Non-Proprietary Name: | amlodipine valsartan and hydrochlorothiazide |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 04-04-2009 |
| Category Name: | NDA |
| Application Number: | NDA022314 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN |
| Active Numerator Strength: | 10; 12.5; 160 |
| Active Ingredient Unit: | mg/1; mg/1; mg/1 |
| Pharm Classes: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |